New Study Reveals Promising Outcomes for Minimally Invasive Sacrospinous Ligament Fixation Using EnPlace® for Treating Pelvic Organ Prolapse in Older Women
17 oct. 2024 10h00 HE
|
FEMSelect Ltd.
NEWARK, Del., Oct. 17, 2024 (GLOBE NEWSWIRE) -- A new study published last week in the “Journal of Clinical Medicine” has revealed promising results for sacrospinous ligament (SSL) fixation using...
LevLane Advertising Wins PRSA Anvil Award for Best Feature Article Addressing Bias Against Use of Biological Terms in Women's Health Marketing and Advertising
28 mai 2024 08h00 HE
|
LevLane
PHILADELPHIA, May 28, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent full-service advertising agencies, was awarded an Anvil Award for the prestigious...
FEMSelect Launches Consumer Advocacy Campaign To Raise Awareness and Highlight Treatment Options for Pelvic Organ Prolapse
03 août 2023 13h00 HE
|
FEMSelect Ltd.
NEWARK, Del., Aug. 03, 2023 (GLOBE NEWSWIRE) -- FEMSelect Ltd., a women-led company developing groundbreaking solutions to advance women's health, today announced the launch of its Consumer Advocacy...
LevLane Advertising Appointed Agency of Record by FEMSelect Ahead of Consumer Advocacy Campaign
22 juin 2023 10h00 HE
|
LevLane
PHILADELPHIA, June 22, 2023 (GLOBE NEWSWIRE) -- FEMSelect, a women's health company dedicated to providing safe and effective health solutions, has appointed award-winning LevLane Advertising as its...